All Categories
Rare Diseases — It’s All About the Patient
 | Among all the days of the calendar, February 29th is the rarest of them all. That’s why, back in 2008, on the 25th anniversary of the Orphan Drug ACT, EURORDIS (The European Organization for Rare Disorders) designated the last day of February as “Rare Disease Day.” Its purpose was simple: to raise awareness and drive education… Read the full article… |
Planning Amidst the Mayhem
 | Maybe you noticed – 2020 was a crazy year. Like meeting the Pope or becoming a parent for the first time, the phrase “once in a lifetime” keeps popping up in conversation as a way to describe what we are all living through. Hopefully, in the case of last year, the description is on target… Read the full article… |
My Big Announcement
 | I looked out at the Zoom faces of my newly-formed, second company — our software development partner, our SaaS product advisor, and our product head Kristin Fahy (previously with The NemetzGroup), all who wanted to help turn the vision I had into a reality. Internally, we called it “NewCo” (we are nothing, if not creative).… Read the full article… |
Just Do It… the Best You Can with Compassion for Others AND Yourself
 | With six weeks left in the year, this November e-conversation should be all about getting in gear for the 2021 planning cycle. Or, maybe, it should be about Q1, JPM, and how to tell your commercial story in a nanosecond or less. Or how about gratitude, since it is almost Thanksgiving? The fact is, this… Read the full article… |
Reverse Mentoring with Up-and-Coming Talent
 | In the accelerated, high-stakes world of biopharma, thinking big, thinking fast, and thinking smart, isn’t just an option — it’s a priority. Why then, are we not tapping into our most educated generation and exploring what millennials have to offer? (A rhetorical question, for sure.) Millennials bring a unique viewpoint, one that not only enables… Read the full article… |
Commercialization Street Smarts to Inform Your S-1 Business Section
 | Over the past several years, The NemetzGroup has worked with numerous clients to develop key aspects of their S-1 filings — coordinating with bankers, attorneys, internal staff, and many more attorneys, all with the goal of helping these companies achieve successful public offerings. Within the S-1, effective crafting of the Business Section is critical. If you… Read the full article… |
An Abundance of Riches in Uncertain Times
 | Pandemic or not, our industry continues to speed along at an accelerated pace. Of course, the routines have changed — virtual calls instead of conference rooms, homemade coffee instead of a morning meeting at the nearest Starbucks, and much more. But the work itself continues, unabated. As part of our mission to support early- to mid-stage… Read the full article… |
There Is No Such Thing as a Free Launch!
 | One of the things I’ve enjoyed about working with The NemetzGroup is the exposure to so many organizations and the amazing work they are doing for patients. We are fortunate to work with clients of all sizes, whose products are at various stages of their life cycle. But the angst around how to achieve a… Read the full article… |
Making Virtual Workshops Work
 | Workshops, whether in the form of a half-day strategy session, a company-wide offsite or some other configuration, have one thing in common: They represent an opportunity for a group of people to come together in real time — to establish connections, share information, generate solutions, and achieve clear objectives. When done well, they are more… Read the full article… |
Industry Leaders Speak
 | Over the past month, Frank Dolan of Arsenal Advisors has interviewed more than 30 leaders and experts in our industry — one each day and still counting! Among those interviewed were leaders in biopharma companies, industry influencers, digital marketing firms, media figures, and advisors. The conversations were wide-ranging (I listened to nearly all of them), covering leadership,… Read the full article… |